CORIXA CORP·4

Jul 14, 1:37 PM ET

CORIXA CORP 4

4 · CORIXA CORP · Filed Jul 14, 2005

Insider Transaction Report

Form 4
Period: 2005-07-12
FANNING DAVID
Sr. Vice President, COO
Transactions
  • Disposition to Issuer

    Non-Qualified Stock Option

    2005-07-1210,9380 total
    Exercise: $6.41From: 2005-07-12Exp: 2013-01-03Common Stock (10,938 underlying)
  • Exercise/Conversion

    Common Stock

    2005-07-12$3.95/sh+150,000$592,500181,026 total
  • Disposition to Issuer

    Common Stock

    2005-07-12$4.40/sh150,000$660,00031,026 total
  • Disposition to Issuer

    Common Stock

    2005-07-12$4.40/sh31,026$136,5140 total
  • Exercise/Conversion

    Incentive Stock Option

    2005-07-12150,0000 total
    Exercise: $3.95From: 2005-07-12Exp: 2014-12-15Common Stock (150,000 underlying)
  • Disposition to Issuer

    Incentive Stock Option

    2005-07-1221,0940 total
    Exercise: $6.04From: 2005-07-12Exp: 2013-12-31Common Stock (21,094 underlying)
  • Disposition to Issuer

    Incentive Stock Option

    2005-07-124,0620 total
    Exercise: $6.41From: 2005-07-12Exp: 2013-01-03Common Stock (4,062 underlying)
  • Disposition to Issuer

    Incentive Stock Option

    2005-07-1246,7930 total
    Exercise: $10.40From: 2005-07-12Exp: 2011-10-01Common Stock (46,793 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option

    2005-07-12253,2070 total
    Exercise: $10.40From: 2005-07-12Exp: 2011-10-01Common Stock (253,207 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option

    2005-07-1250,0000 total
    Exercise: $6.70From: 2005-07-12Exp: 2012-10-04Common Stock (50,000 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option

    2005-07-1275,0000 total
    Exercise: $5.70From: 2005-07-12Exp: 2014-12-15Common Stock (75,000 underlying)
  • Disposition to Issuer

    Non-Qualified Stock Option

    2005-07-1219,4060 total
    Exercise: $6.04From: 2005-07-12Exp: 2013-12-31Common Stock (19,406 underlying)
Footnotes (2)
  • [F1]Pursuant to the Merger Agreement with GSK, these options were cancelled at the time the merger. Net cash consideration was received.
  • [F2]Pursuant to the Merger Agreement with GSK, the underlying option was cancelled cancelled at the time of the Merger. No cash consideration was received for the cancellation.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION